Home Venture Capital “8 Questions with Playfair” ft. Rayna Patel @ Vinehealth | by Chris Smith | Playfair Weblog

“8 Questions with Playfair” ft. Rayna Patel @ Vinehealth | by Chris Smith | Playfair Weblog

“8 Questions with Playfair” ft. Rayna Patel @ Vinehealth | by Chris Smith | Playfair Weblog


That is the nineteenth in our “8 Questions” sequence — during which we sit down with founders within the Playfair portfolio who share their entrepreneurial journey.

We first invested in Vinehealth, a worldwide oncology platform combining behavioural science and AI to ship scalable personalised care and resarch, in 2019. Since then, the corporate has constructed a internationally scalable platform, obtained regulatory approval, labored with a few of the world’s main hospitals to assist most cancers sufferers and signed industrial offers with tier 1 pharma firms throughout a number of product strains.

At present, we sit down with co-founder and CEO, Rayna Patel, to listen to her story from the beginnings of Vinehealth. We hope this might help different founders and aspirational entrepreneurs in their very own ventures.

My profession ambitions have at all times been what the tech sector would name ‘mission-driven’. At first, that manifested in turning into a health care provider, however experiencing the inefficiencies and frustration of ‘what might be’ in healthcare impressed me to wish to change issues for the higher and I felt very motivated by the potential to do that at scale. I imagine wholeheartedly that expertise has a core position to play in reworking our healthcare programs to change into sustainable, efficient and patient-centric, and to me that makes this job extremely thrilling and fulfilling.

On a private stage, I like drawback fixing, being scrappy and relish discovering artistic methods to do issues in a different way so the day-to-day job of being a founder precisely fits the best way I wish to function.

For me, the roots of Vinehealth have been began in my time on the Cupboard Workplace’s Behavioural Insights Crew. As a part of the Ventures crew, operationalising behavioural science into scalable expertise, I acquired the bug for constructing tech and had the chance to mix this with my ardour for behavioural science.

Vinehealth started in earnest after I met Georgina at Entrepreneur First and we realised we’d seen the identical drawback from two angles. I’d skilled the affect of lack of patient-reported knowledge on medical care and, as an information scientist constructing AI-driven well being tech, Georgina had put this into observe; utilizing algorithms to precisely predict affected person development and outcomes.

We each understood that the mixture of our backgrounds and the timing in an trade context put us able to construct one thing that might actually change drug growth and healthcare supply for the higher — it was a win-win-win for the affected person, supplier and pharma — which isn’t at all times the case with healthcare innovation.

Hiring is the whole lot — the individuals you encompass your self with would be the main determinant of your means to maximally capitalise on alternatives and finally your success or failure. Founders can’t be the whole lot a enterprise wants — it’s as much as you to recognise this and make sure the gaps are crammed.

Simply after COVID appeared, we began working with NHS England and The Royal Marsden to ship our expertise to most cancers sufferers being affected by the dearth of bodily contact mandated by the pandemic. It was an thrilling and significant mission for us however comparatively small scale and UK-focussed. One afternoon, I acquired an electronic mail saying that Vinehealth was up in lights on the face of the NASDAQ constructing in Occasions Sq. in New York to recognise our work in Covid. It was a whole shock to us and completely surreal at that early stage of the corporate.

Zooming out and focussing on the larger image; not simply with respect to your organization however in the marketplace you use in and the tech panorama as an entire. It’s been helpful to study from our buyers how they harness this wider understanding to tell strategic selections.

Communication; I’ve learnt lots from a lot of our buyers on the right way to make a fancy story easy and having generalists on the cap desk has been notably useful right here.

Closing offers with a few of the largest pharma firms on the earth has been notably satisfying, realizing that they’re funding work that can actually profit sufferers and society. These giant companies hardly ever work with small companions so their resolution to onboard us is an unbelievable achievement for our crew and an vital validation of our product-market slot in an enormous and rising market.

Vinehealth will generate the world’s richest patient-reported dataset in oncology, enabling quicker growth of higher therapies for a illness that 1 in 2 of us will expertise.

Within the quick future, we’re increasing into the US, quickly rising our pharma footprint and focussed on making the person expertise a pleasure from begin to end. I’m very excited to see what our unbelievable crew will obtain in 2023.

Ignore the stereotypes. Notably as a feminine founder, it’s simple to see the standard mould of a venture-backed founder and never see your self referring to it. There’s the strain of the best way fundraising is made to appear and feel — an impression that you must pull off an excessive stage of hubris otherwise you received’t be seen as ‘hungry’ sufficient. In my view, you shouldn’t must be something aside from obsessed with what you’re doing, decided to realize it and have a real progress mindset, so if you would like be a founder — go for it! (and do it your approach).



Please enter your comment!
Please enter your name here